Filing Details
- Accession Number:
- 0000749647-11-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-31 12:00:50
- Reporting Period:
- 2011-05-26
- Filing Date:
- 2011-05-31
- Accepted Time:
- 2011-05-31 12:00:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
749647 | Celsion Corp | CLSN | Pharmaceutical Preparations (2834) | 521256615 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1251779 | L Gregory Weaver | C/O Celsion Corporation 10220-L Old Columbia Road Columbia MD 21046 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Celsion Corporation Common Stock | Acquisiton | 2011-05-26 | 8,636 | $2.77 | 23,636 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Celsion Corporation Common Stock | Warrants to purchase Common Stock | Acquisiton | 2011-05-26 | 8,636 | $0.13 | 8,636 | $2.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,636 | 2011-11-26 | 2017-05-26 | No | 4 | P | Direct |
Footnotes
- The securities were purchased in a private placement transaction dated May 26, 2011 between Celsion Corporation and institutional investors as well as certain officers and directors of Celsion Corporation.
- Represents the closing consolidated bid price as reported on NASDAQ on the date of the transaction.
- Each warrant to purchase one share of common stock was purchased for $0.125 per unit, which represents the value allocated to the warrant in accordance with the NASDAQ Stock Market Rules.